Trump Administration Freezes Federal Health Agency Communications Until Further Notice

The Trump administration has temporarily halted public communications from several federal health agencies. This freeze, lasting until at least the end of the month, was detailed in a memo obtained by The Associated Press. Dorothy Fink, acting secretary of the Department of Health and Human Services (HHS), instructed agency leaders to pause regulations, guidance, announcements, and social media posts until they receive approval from a political appointee.

The freeze affects communications intended for the Federal Register and the Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention (CDC). Agencies like the CDC, National Institutes of Health, and Food and Drug Administration are impacted. These organisations are crucial in managing epidemics, ensuring food safety, and researching disease cures. HHS officials did not comment on this pause, which was initially reported by The Washington Post.

Impact on Public Health Communication

Peter Lurie, president of the Center for Science in the Public Interest, expressed concern over this communication halt. He stated that Americans rely on timely updates from agencies like the CDC and FDA to prevent foodborne illnesses and stay informed about health issues. "When it comes to stopping outbreaks, every second counts," Lurie emphasised in a statement.

Jeffrey Klausner from the University of Southern California echoed these concerns. He highlighted that local health officials depend on the CDC for disease updates and guidelines. "Shutting down public health communication stops a basic function of public health," Klausner noted. He compared it to turning off fire sirens or other warning systems.

Exceptions and Concerns

Fink's memo mentioned exceptions for communications related to critical health, safety, environmental, financial, or national security functions. However, these exceptions would still require review. Despite this provision, there is concern about potential delays in publishing urgent alerts during active outbreaks due to vague directives.

Ali Khan, former CDC outbreak investigator and current dean at the University of Nebraska's public health college, commented on the situation. He acknowledged that pauses are typical during transitions but warned against reverting to silencing agencies for political narratives.

Steven Grossman, a former HHS official now consulting for food and drug companies, explained that new administrations often pause communications to establish hierarchy. "Whether stated publicly or not," he said in an email, "every new administration wants important commitments and positions to wait until new teams are in place."

During Trump's first term, political appointees attempted to control the CDC's MMWR journal. This journal had published information about COVID-19 that conflicted with White House messaging. The current pause raises concerns about similar attempts to influence agency communications.

The FDA recently posted notices about warning letters sent to companies and a drug safety notice despite the freeze. This indicates some level of ongoing communication amidst the restrictions imposed by the administration.

As February 1 approaches, it remains uncertain how long this communication freeze will last or what its long-term implications might be for public health agencies and their ability to disseminate crucial information promptly.